Colon Cancer. Malignant neoplasm of colon
Conditions
Interventions
Intervention 1: Control group will receive placebo in 2 times a day for 3 months. Placebo is wheat flour in capsules. Intervention 2: Intervention group will receive Ubiqionon 200 milligram daily for
Placebo
Treatment - Drugs
Control group will receive placebo in 2 times a day for 3 months. Placebo is wheat flour in capsules.
Intervention group will receive Ubiqionon 200 milligram daily for 3 months before commencement of chemotherapy.Patient will receive 2 times a day of Canadian 100 milligram Ubiquinon by domestic pharma
Sponsors
Vice Challencer for Research Ahwaz Jundishapur University of Medical Science
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: age between 30 to 70; healthy function of liver and kidney; Colon cancer diagnosis Exclusion Criteria: Chemotherapy; Food supplement or other dietary regimen; Diabetes patients
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 8-Oxo-2'-deoxyguanosine. Timepoint: before intervention and 3 month after that. Method of measurement: Immunohistochemistry.;MutL homolog 1. Timepoint: before intervention and 3 month after that. Method of measurement: Immunohistochemistry.;MutS homolog 1. Timepoint: before intervention and 3 month after that. Method of measurement: Immunohistochemistry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Wieght. Timepoint: before intervention and3 monthsafter that. Method of measurement: sensitive Balance. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Ahmadzadeh
Ahwaz Jundishapoor University of Medical Science
Outcome results
None listed